Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników

Znaleziono wyników: 13

Liczba wyników na stronie
Pierwsza strona wyników Pięć stron wyników wstecz Poprzednia strona wyników Strona / 1 Następna strona wyników Pięć stron wyników wprzód Ostatnia strona wyników

Wyniki wyszukiwania

Wyszukiwano:
w słowach kluczowych:  veterinary drug
help Sortuj według:

help Ogranicz wyniki do:
Pierwsza strona wyników Pięć stron wyników wstecz Poprzednia strona wyników Strona / 1 Następna strona wyników Pięć stron wyników wprzód Ostatnia strona wyników
The year 1899 can be regarded as the beginning of the production of medications for animals in the Polish territories, for it was then that biological preparations made at the Department of Hygiene of the Jagiellonian University in Kraków were first mentioned by the press. The interwar period saw the development of not only the veterinary and bioveterinary industry, but also legislation that regulated its functioning. Although very advanced for those times, those laws were also susceptible to different interpretations and could easily be circumvented. In 1939, there were 33 Polish companies producing synthetic preparations and 6 producing serums and vaccines. One serious problem of the Polish pharmaceutical industry was the deficiency of domestic investment capital. The foreign ownership of the pharmaceutical industry amounted to 30%. Polish serums and vaccines for humans and animals fully covered the country’s needs and represented the strongest branch of the domestic pharmaceutical industry (in 1939, the Polish production of medicines met 3/4 of domestic demand). The development of industrial pharmacy in Poland was stopped by the outbreak of the Second World War. Many buildings were destroyed already at the beginning of the war in 1939. Post-war years showed that the foundations of the Polish pharmaceutical industry (including its veterinary branch) were solid. Polish pharmaceutical companies mostly recovered and sometimes even expanded their productive potential after the war.
A liquid chromatography-tandem mass spectrometry (LC-MS/MS) method has been developed for the determination of metabolites of furazolidone, furaltadone, nitrofurantoin, and nitrofurazone in eggs. The procedure requires an acid-catalysed release of protein-bound metabolites, followed by their in situ conversion into the 2- nitrobenzaldehyde (NBA) derivatives. The sample cleanup was performed on a solid phase extraction (SPE) cartridge. LC- MS/MS analysis was performed by positive electrospray ionisation (ESI) applying multiple reaction monitoring (MRM) of two transition reactions for each compound. The validation of the method was conducted following the European Union criteria for the analysis of veterinary drug residues in foods. The decision limits (CCα) were 0.16-0.24 µg/kg, and the detection capabilities (CCβ) 0.22-0.36 µg/ kg.
The sensitivity of three microbiological antibiotic residue screening methods - the Four Plate Test (FPT), the Screening Test for Antibiotic Residues (STAR) and the Premi®Test - was compared for the detection of 10 different standards from the sulphonamide (SA) group. Phtalylsulphathiazole (PHT), sulphadimidine (SD), sulphaguanidine (SG), sulphachlorpyridazine (SCHP), sulphamerazine (SRZ), sulphamethoxazole (SMX), sulphanilamid (SAM), sulphanilic acid (SAC), sulphaquinoxaline (SQ) and sulphathiazole (STZ) were tested using the concentrations from 0.05 µg.ml⁻¹ to 1 µg.ml⁻¹. The detection sensitivity of the methods represented by minimum inhibiting concentrations (MIC) of SA standards was evaluated. The MIC of SAs represent the detection limits of methods (LOD) for individual substances. The MIC of SA standards detected by the FPT was 0.2 µg.ml⁻¹ for SMX, STZ, SQ and SRZ, 0.3 µg.ml⁻¹ for SCHP, and 0.4 µg.ml⁻¹ for SD. The MIC of SA standards detected by the STAR was 0.05 µg.ml⁻¹ for SMX, STZ, SQ and SCHP, 0.1 µg.ml⁻¹ for SRZ, and 0.3 µg.ml⁻¹ for SD. No detection sensitivity of either method was observed for SAM, SAC, SG and PHT standards. The MIC of SA standards detected by Premi®Test was 0.05 µg.ml⁻¹ for SMX, STZ, SQ, SCHP, SRZ and SD, 0.1 µg.ml⁻¹ for PHT, 0.2 µg.ml⁻¹ for SAM, and 0.3 µg.ml⁻¹ for SAC and SG. The results of the tests showed that Premi®Test is the most sensitive method to detect Sas, followed by the STAR and the FPT methods. The inhibitory effect of para-aminobenzoic acid (PABA) toward the residual concentrations of SA standards was evaluated. The reference PABA concentrations for the confirmation of the presence of all SAs detected by the FPT and the STAR was 1 µg.ml⁻¹ and 10 µg.ml⁻¹ for the Premi®Test. In the authors’ opinion, the presented concentration of PABA can be recommended for a reliable confirmation of the presence of SA residues even at concentrations that present a potential risk to human health.
Pierwsza strona wyników Pięć stron wyników wstecz Poprzednia strona wyników Strona / 1 Następna strona wyników Pięć stron wyników wprzód Ostatnia strona wyników
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.